Risk for hepatitis B and C virus reactivation in patients with psoriasis on biologic therapies: A retrospective cohort study and systematic review of the literature

Patients with psoriasis on biologic therapies and a history of viral hepatitis carry a risk for reactivation.

http://ift.tt/2q1RTHU